According to the report Europe Influenza Market, published by Market Data Forecast, the Europe market is projected to reach USD xx billion by 2022, at a CAGR of xx% from 2017 to 2022
PR-Inside.com: 2017-12-07 12:42:32
Influenza virus causes an infectious disease known as Influenza. It is commonly known as flu. Symptoms generally include sore throat, high fever, muscle pains, cough and headache. The symptoms usually last for 4-7 days. The virus spreads form person to person through air medium or touch. Several vaccines and drugs are available for influenza. Vaccines can prevent some types of virus only. Children have a high risk of acquiring the disease than adults.
Get a comprehensive overview of the Europe Influenza Market: www.marketdataforecast.com/market-reports/europe-influenza-marke ..
Europe Influenza Market: Drivers & Restraints
Growing healthcare expenditure due to increasing per capita income of people, advances in healthcare and drug development and government initiatives for vaccination against influenza are the major factors driving the market growth. Growing awareness among general population and introduction of new drugs and vaccines are also driving the market growth.
However, increase in the use of generic drugs, shift in antigens of influenza virus and strict regulations are hindering the market growth.
Get accurate market forecast and analysis on the Europe Influenza Market. Request a sample to stay up-to-date on the main trends affecting this market: www.marketdataforecast.com/market-reports/europe-influenza-marke ..
Europe Influenza Market: Segmentation
By Product Type
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at: www.marketdataforecast.com/market-reports/europe-influenza-marke ..
Europe Influenza Market: Overview
Based on the product type, Vaccines hold the largest market share due to the large number of government initiatives to encourage the usage of vaccines and increasing awareness of vaccination. Based on consumer, children segment holds the largest market share because children are more prone to develop influenza due to the weak immune system. Mortality rate due to influenza is also high in children.
Germany has the biggest share for the Europe Influenza Market and also has a good growth rate. United Kingdom is growing at the fastest rate.
Europe Influenza Market: Key Players
Major players in the Europe Influenza Market are F. Hoffmann-La Roche, Sanofi-Pasteur, GlaxoSmithKline, AstraZeneca, Novartis, Abbott Laboratories, Pfizer Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, and CSL Limited.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com
Market Data Forecast
531/MIG-II, Rd Number 1, Kukatpally Housing Board Colony, Kukatpally, Hyderabad, Telangana
# 482 Words